ADTX
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
NRBO
Price
$2.56
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

ADTX vs NRBO

Header iconADTX vs NRBO Comparison
Open Charts ADTX vs NRBOBanner chart's image
Aditxt
Price$0.35
Change-$0.00 (-0.00%)
Volume$857.66K
CapitalizationN/A
NeuroBo Pharmaceuticals
Price$2.56
Change-$0.00 (-0.00%)
Volume$70.84K
CapitalizationN/A
ADTX vs NRBO Comparison Chart
Loading...
ADTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NRBO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ADTX vs. NRBO commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADTX is a Hold and NRBO is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ADTX: $0.35 vs. NRBO: $2.56)
Brand notoriety: ADTX and NRBO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADTX: 24% vs. NRBO: 133%
Market capitalization -- ADTX: $3.04M vs. NRBO: $21.73M
ADTX [@Biotechnology] is valued at $3.04M. NRBO’s [@Biotechnology] market capitalization is $21.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADTX’s FA Score shows that 1 FA rating(s) are green whileNRBO’s FA Score has 0 green FA rating(s).

  • ADTX’s FA Score: 1 green, 4 red.
  • NRBO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADTX and NRBO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADTX’s TA Score shows that 2 TA indicator(s) are bullish while NRBO’s TA Score has 4 bullish TA indicator(s).

  • ADTX’s TA Score: 2 bullish, 2 bearish.
  • NRBO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NRBO is a better buy in the short-term than ADTX.

Price Growth

ADTX (@Biotechnology) experienced а -26.76% price change this week, while NRBO (@Biotechnology) price change was -6.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +6.16%.

Reported Earning Dates

ADTX is expected to report earnings on Nov 29, 2023.

NRBO is expected to report earnings on Mar 29, 2024.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRBO($21.7M) has a higher market cap than ADTX($3.04M). NRBO YTD gains are higher at: -30.747 vs. ADTX (-99.869). NRBO has higher annual earnings (EBITDA): -23.09M vs. ADTX (-33.14M). NRBO has more cash in the bank: 27.9M vs. ADTX (91.2K). NRBO has less debt than ADTX: NRBO (170K) vs ADTX (7.89M). ADTX has higher revenues than NRBO: ADTX (330K) vs NRBO (0).
ADTXNRBOADTX / NRBO
Capitalization3.04M21.7M14%
EBITDA-33.14M-23.09M144%
Gain YTD-99.869-30.747325%
P/E RatioN/A13.00-
Revenue330K0-
Total Cash91.2K27.9M0%
Total Debt7.89M170K4,643%
FUNDAMENTALS RATINGS
NRBO: Fundamental Ratings
NRBO
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADTXNRBO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 9 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ADTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NRBO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TANH0.170.02
+15.81%
Tantech Holdings Ltd
MPU1.750.16
+10.06%
Mega Matrix Inc
STN82.590.35
+0.43%
Stantec
SHO10.44-0.07
-0.67%
Sunstone Hotel Investors
MSBI27.09-0.25
-0.93%
Midland States Bancorp

ADTX and

Correlation & Price change

A.I.dvisor tells us that ADTX and ORMP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADTX and ORMP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADTX
1D Price
Change %
ADTX100%
-5.82%
ORMP - ADTX
32%
Poorly correlated
-0.64%
NRBO - ADTX
31%
Poorly correlated
N/A
CSCI - ADTX
28%
Poorly correlated
+8.33%
XTLB - ADTX
27%
Poorly correlated
N/A
BDRX - ADTX
25%
Poorly correlated
-3.39%
More

NRBO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRBO has been loosely correlated with TCRT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NRBO jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRBO
1D Price
Change %
NRBO100%
N/A
TCRT - NRBO
50%
Loosely correlated
-1.64%
ARGX - NRBO
45%
Loosely correlated
+0.88%
BLUE - NRBO
37%
Loosely correlated
-3.12%
SYRE - NRBO
37%
Loosely correlated
-7.94%
AKRO - NRBO
32%
Poorly correlated
-4.35%
More